Alimta

... Salt Lake Tribune - Business WORLD CLASSIFIEDS Quick Search Enter search term Advanced Search Business Stocks WSJ Sunday News Contents Past Content Photos Obituaries Archives Utah Politics Drought Closeup Columnists TribTalk Forums Weather Ski Report Opinion Bagley Cartoons Editorials Commentary Public Forum Sports Real Salt Lake Stingers Utah Jazz College Sports Prep Sports Features Film Finder Arts Travel Home & Family Health & Science Food Outdoors The Mix Faith Entertainment Lifestyle Shopping Classifieds Retail Ads Cars/RVs Real Estate Jobs Education Guide Bride Guide Utah City Guide Hotel Rooms Grocery Guru Fantasy Sports Buy/Sell Tickets Advertising Info Bus./Industry Utah Community News Extras TribTalk Forums Not in Print NIE Reader Panel Crossword Services Help Desk FAQ Contact Us Subscribe Privacy Policy Link To Article Print Article Email Article Article Last Updated: 04/13/2005 11:29:54 PM Modest Q1 looms for drug makers By Greg Groeller Dow Jones Newswires rimmer:td NEW YORK - U.S.

drug makers are expected to report a lackluster first quarter, reflecting an ongoing struggle with product withdrawals, a dearth of new drugs in the pipeline and increased competition from generics.

Profits at most major drug makers will be driven by the companies' ability to hold down costs, rather than by bringing in more revenue from...

Read more...